Treatment.com International (TREIF)
OTHER OTC:TREIF

Treatment.com International (TREIF) Stock Price & Analysis

13 Followers

TREIF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.02 - $0.91
Previous Close$0.85
Volume33.10K
Average Volume (3M)28.46K
Market Cap
$35.90M
Enterprise Value$34.62M
Total Cash (Recent Filing)C$2.30M
Total Debt (Recent Filing)C$561.29K
Price to Earnings (P/E)
Beta0.01
Aug 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding38,080,115
10 Day Avg. Volume7,967
30 Day Avg. Volume28,462
Standard Deviation0.30
R-Squared0.00525
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)-8.87
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-123.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

26.75%0.00%0.00%73.25%
26.75% Insiders
0.00% Other Institutional Investors
73.25% Public Companies and
Individual Investors

TREIF FAQ

What was Treatment.com International’s price range in the past 12 months?
Treatment.com International lowest stock price was $0.02 and its highest was $0.91 in the past 12 months.
    What is Treatment.com International’s market cap?
    Currently, no data Available
    When is Treatment.com International’s upcoming earnings report date?
    Treatment.com International’s upcoming earnings report date is Aug 27, 2024 which is in 31 days.
      How were Treatment.com International’s earnings last quarter?
      Currently, no data Available
      Is Treatment.com International overvalued?
      According to Wall Street analysts Treatment.com International’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Treatment.com International pay dividends?
        Treatment.com International does not currently pay dividends.
        What is Treatment.com International’s EPS estimate?
        Treatment.com International’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Treatment.com International have?
        Treatment.com International has 46,239,017 shares outstanding.
          What happened to Treatment.com International’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Treatment.com International?
          Currently, no hedge funds are holding shares in TREIF
          ---

          Treatment.com International Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Positive
          20 days / 200 days
          Momentum
          12.43%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          9999.00%
          Trailing 12-Months

          Company Description

          Treatment.com International

          Treatment.com International Inc operates in the mobile health, digital health, telemedicine, and artificial intelligence segments of the global health industry. Its first commercial mobile application is an internally-developed medical intelligence platform, code-named as MERLIN. Multiple pre-production versions of MERLIN are running in multiple Google Cloud Datacenters in the U.S., Canada, and Singapore. The scale and scope of Google Cloud Services provide the company with the data centers and software services needed to provide its diagnostic and treatment services to a global customer base, in multiple languages.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Teladoc
          American Well
          Guardant Health
          Aptose Biosciences
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis